JJA-11608-71249

4 vaccinations 5 coded responses 26 check-ins 5 free-text entries 6 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 537 / WI
Registered: 2021-01-02

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-02
Registered in v-safe
2021-01-02
Dose 1 — Pfizer-BioNTech
2021-01-02
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-01-04
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-05
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-05
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-06
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-07
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — day 7, dose 1
Feeling: Good · Fever · Fatigue or tiredness

Adult check-in
2021-01-23
Dose 2 — Pfizer-BioNTech
2021-01-23
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-01-24
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-25
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Pleuritic pain — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Free text: Shortness of breath, pleuritic pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-30
Health check-in — day 7, dose 2
Feeling: Fair · Joint pains

Adult check-in
2021-02-06
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-22
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-01
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-06
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-24
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-06-03
Call 1 — Could Not Reach Participant
2021-07-24
Survey response — 6 months, dose 2
MedDRA: Pre-existing disease, Systemic lupus erythematosus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Lupus flare x 1 week, ongoing

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-24
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-02
Call 1 — Left Voicemail
2021-10-02
Dose 3 — Pfizer-BioNTech
2022-01-24
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-03-05
Dose 4 — Pfizer-BioNTech
2022-04-21
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-06-06
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-02	Pfizer-BioNTech
2	2021-01-23	Pfizer-BioNTech
3	2021-10-02	Pfizer-BioNTech	No
4	2022-03-05	Pfizer-BioNTech	No

Call center

6 call center cases

2 unsuccessful · 4 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-25

Systemic reaction (other): Shortness of breath, pleuritic pain

2021-01-26

Systemic reaction (other): Shortness of breath

2021-01-27

Systemic reaction (other): Shortness of breath

2021-01-28

Systemic reaction (other): Shortness of breath

Release 9 — 6 months, dose 2

2021-07-24

Symptoms: Lupus flare x 1 week, ongoing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pre-existing disease	✓	·	✓
SD	Systemic lupus erythematosus	✓	·	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Pleuritic pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release